Lyra Therapeutics - Lyra Therapeutics

We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics Stock: Promising Data For Sinus Treatment (NASDAQ:LYRA)

Lyra Therapeutics appoints Richard Nieman as CMO - Medical Buyer

Lyra Therapeutics - Lyra Therapeutics

Lyra Therapeutics, Inc.

Lyra's $100M private placement is music to the ears (and nose and throat)

Lyra Therapeutics on LinkedIn: Lyra Therapeutics Announces Appointment of Ronan O'Brien as Chief Legal…

Lyra Therapeutics (LYRA) Shares Decline After Favorable Topline Results From LYR-210 Study

Ashley Hankins, MBA on LinkedIn: Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2…

Lyra Therapeutics (@LyraTx) / X

Colin Walters on LinkedIn: Culture - Lyra Therapeutics

Lyra Therapeutics enrolls first patient in rhinosinusitis trial

Lyra Therapeutics: Worthy Of A Small Bet (NASDAQ:LYRA)